Lu Fu

870 total citations
40 papers, 641 citations indexed

About

Lu Fu is a scholar working on Molecular Biology, Plant Science and Infectious Diseases. According to data from OpenAlex, Lu Fu has authored 40 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Plant Science and 7 papers in Infectious Diseases. Recurrent topics in Lu Fu's work include Natural product bioactivities and synthesis (8 papers), Phytochemistry and Biological Activities (8 papers) and Computational Drug Discovery Methods (5 papers). Lu Fu is often cited by papers focused on Natural product bioactivities and synthesis (8 papers), Phytochemistry and Biological Activities (8 papers) and Computational Drug Discovery Methods (5 papers). Lu Fu collaborates with scholars based in China, Australia and United States. Lu Fu's co-authors include Megan S. Lord, Ye Bi, Lesheng Teng, Cuicui Li, Xinyong Liu, Peng Zhan, Erik De Clercq, Boshi Huang, Huiqing Liu and Christophe Pannecouque and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Functional Materials and Advanced Drug Delivery Reviews.

In The Last Decade

Lu Fu

37 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Fu China 13 214 112 101 98 89 40 641
Hemant Joshi India 17 210 1.0× 102 0.9× 90 0.9× 82 0.8× 40 0.4× 45 883
Sandip S. Chavhan India 10 220 1.0× 78 0.7× 57 0.6× 180 1.8× 38 0.4× 12 816
Sulabha Pathak India 19 370 1.7× 39 0.3× 44 0.4× 94 1.0× 36 0.4× 31 1.1k
Rajendra Kumar India 20 293 1.4× 189 1.7× 104 1.0× 229 2.3× 24 0.3× 60 1.1k
Vikash Jakhmola India 14 301 1.4× 65 0.6× 34 0.3× 76 0.8× 20 0.2× 97 746
Sahil Kumar India 11 235 1.1× 94 0.8× 234 2.3× 131 1.3× 32 0.4× 46 760
Kunihiro Kaihatsu Japan 16 566 2.6× 75 0.7× 80 0.8× 32 0.3× 45 0.5× 44 999
Rupesh K. Gautam India 16 284 1.3× 89 0.8× 44 0.4× 94 1.0× 51 0.6× 67 781
Nguyen Thanh Nguyen United States 12 310 1.4× 31 0.3× 78 0.8× 24 0.2× 48 0.5× 29 693
Mehboob Hoque India 13 249 1.2× 108 1.0× 45 0.4× 74 0.8× 18 0.2× 42 633

Countries citing papers authored by Lu Fu

Since Specialization
Citations

This map shows the geographic impact of Lu Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Fu more than expected).

Fields of papers citing papers by Lu Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Fu. The network helps show where Lu Fu may publish in the future.

Co-authorship network of co-authors of Lu Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Fu. A scholar is included among the top collaborators of Lu Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Fu. Lu Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Lu, Jonathan Yeow, Miriam Jackson, et al.. (2025). The interplay between endothelial glycocalyx maturity and both the toxicity and intracellular uptake of charged nanoparticles. Acta Biomaterialia. 196. 293–306. 2 indexed citations
2.
3.
Fu, Lu, et al.. (2025). Functionalized Cerium Oxide Nanoparticles Enhance Penetration into Melanoma Spheroids In Vivo through Angiogenesis. Advanced Healthcare Materials. 14(12). e2405129–e2405129. 2 indexed citations
4.
Li, Xin, Xia Mao, Hong Jiang, et al.. (2024). Shirebi granules ameliorate acute gouty arthritis by inhibiting NETs-induced imbalance between immunity and inflammation. Chinese Medicine. 19(1). 105–105. 4 indexed citations
5.
Fu, Lu, Ha Na Kim, Catherine Ding, et al.. (2024). Cationic Polysaccharides Bind to the Endothelial Cell Surface Extracellular Matrix Involving Heparan Sulfate. Biomacromolecules. 25(6). 3850–3862. 3 indexed citations
6.
Tan, Richard P., Edward S. X. Moh, Lu Fu, et al.. (2024). Tuning Recombinant Perlecan Domain V to Regulate Angiogenic Growth Factors and Enhance Endothelialization of Electrospun Silk Vascular Grafts. Advanced Healthcare Materials. 13(23). e2400855–e2400855. 2 indexed citations
7.
Liu, Jiazheng, Lu Fu, Tong Shu, et al.. (2023). Anti-Entry Activity of Natural Flavonoids against SARS-CoV-2 by Targeting Spike RBD. Viruses. 15(1). 160–160. 21 indexed citations
8.
Tian, Sai, Jinbo Zhang, Shunling Yuan, et al.. (2023). Exploring pharmacological active ingredients of traditional Chinese medicine by pharmacotranscriptomic map in ITCM. Briefings in Bioinformatics. 24(2). 60 indexed citations
9.
Fu, Lu, Anyu Zhang, Behnam Akhavan, et al.. (2023). Recombinant perlecan domain V covalently immobilized on silk biomaterials via plasma immersion ion implantation supports the formation of functional endothelium. Journal of Biomedical Materials Research Part A. 111(6). 825–839. 12 indexed citations
10.
Zhang, Yanqiong, Xin Li, Yulong Shi, et al.. (2023). ETCM v2.0: An update with comprehensive resource and rich annotations for traditional Chinese medicine. Acta Pharmaceutica Sinica B. 13(6). 2559–2571. 65 indexed citations
11.
Kim, Ha Na, Zehra Elgundi, Xiaoting Lin, et al.. (2023). Engineered short forms of perlecan enhance angiogenesis by potentiating growth factor signalling. Journal of Controlled Release. 362. 184–196. 14 indexed citations
12.
Liu, Jian, et al.. (2022). Genetically Encoded Synthetic Beta Cells for Insulin Biosynthesis and Release under Hyperglycemic Conditions. Advanced Functional Materials. 32(18). 17 indexed citations
13.
Fu, Lu, Ha Na Kim, James D. Sterling, S Baker, & Megan S. Lord. (2022). The role of the cell surface glycocalyx in drug delivery to and through the endothelium. Advanced Drug Delivery Reviews. 184. 114195–114195. 28 indexed citations
14.
Fu, Lu, et al.. (2020). Preparation and in vitro activity of single chain antibodies against Alzheimer's disease. Immunology Letters. 227. 1–7. 10 indexed citations
15.
Zhang, Tao, Qiubo Zhang, Lu Fu, et al.. (2019). New antiproliferative germacranolides from Carpesium divaricatum. RSC Advances. 9(20). 11493–11502. 6 indexed citations
16.
Fu, Lu, Xiaoyu Jiang, Shanshan Guan, et al.. (2016). Expression of HIV-1 broadly neutralizing antibodies mediated by recombinant adeno-associated virus 8 in vitro and in vivo. Molecular Immunology. 80. 68–77. 5 indexed citations
17.
Fu, Lu, Hao Jin, Bin Yu, et al.. (2016). Characterization of NoV P particle-based chimeric protein vaccines developed from two different expression systems. Protein Expression and Purification. 130. 28–34. 4 indexed citations
18.
Huang, Boshi, Cuicui Li, Wen‐Ming Chen, et al.. (2015). Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: Optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches. European Journal of Medicinal Chemistry. 92. 754–765. 82 indexed citations
19.
Fu, Lu, Yuhua Shi, Shanshan Guan, et al.. (2015). Elicitation of HIV-1 neutralizing antibodies by presentation of 4E10 and 10E8 epitopes on Norovirus P particles. Immunology Letters. 168(2). 271–278. 10 indexed citations
20.
Huang, Boshi, Xin Liang, Cuicui Li, et al.. (2015). Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 4: Design, synthesis and biological evaluation of novel imidazo[1,2-a]pyrazines. European Journal of Medicinal Chemistry. 93. 330–337. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hemant Joshi Breakdown of academic impact, for papers by Sandip S. Chavhan Breakdown of academic impact, for papers by Sulabha Pathak Breakdown of academic impact, for papers by Rajendra Kumar Breakdown of academic impact, for papers by Vikash Jakhmola Breakdown of academic impact, for papers by Sahil Kumar Breakdown of academic impact, for papers by Kunihiro Kaihatsu Breakdown of academic impact, for papers by Rupesh K. Gautam Breakdown of academic impact, for papers by Nguyen Thanh Nguyen Breakdown of academic impact, for papers by Mehboob Hoque
Rankless by CCL
2026